Literature DB >> 16790798

Identification of Pseudomonas aeruginosa genes involved in virulence and anaerobic growth.

Melanie J Filiatrault1, Kristin F Picardo, Helen Ngai, Luciano Passador, Barbara H Iglewski.   

Abstract

Pseudomonas aeruginosa is a gram-negative, opportunistic pathogen and a significant cause of acute and chronic infections in patients with compromised host defenses. Evidence suggests that within infections P. aeruginosa encounters oxygen limitation and exists in microbial aggregates known as biofilms. However, there is little information that describes genes involved in anaerobic growth of P. aeruginosa and their association with virulence of this pathogen. To identify genes required for anaerobic growth, random transposon (Tn) mutagenesis was used to screen for mutants that demonstrated the inability to grow anaerobically using nitrate as a terminal electron acceptor. Of approximately 35,000 mutants screened, 57 mutants were found to exhibit no growth anaerobically using nitrate. Identification of the genes disrupted by the Tn revealed 24 distinct loci required for anaerobic growth on nitrate, including several genes not previously associated with anaerobic growth of P. aeruginosa. Several of these mutants were capable of growing anaerobically using nitrite and/or arginine, while five mutants were unable to grow anaerobically under any of the conditions tested. Three mutants were markedly attenuated in virulence in the lettuce model of P. aeruginosa infection. These studies have identified novel genes important for anaerobic growth and demonstrate that anaerobic metabolism influences virulence of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790798      PMCID: PMC1489737          DOI: 10.1128/IAI.02014-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Anaerobic biofilm infections in cystic fibrosis.

Authors:  J William Costerton
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

Review 2.  Mechanisms of antibiotic resistance in bacterial biofilms.

Authors:  Philip S Stewart
Journal:  Int J Med Microbiol       Date:  2002-07       Impact factor: 3.473

Review 3.  Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.

Authors:  P A Lambert
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

4.  Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment.

Authors:  Victoria E Wagner; Daniel Bushnell; Luciano Passador; Andrew I Brooks; Barbara H Iglewski
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

5.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

6.  Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections.

Authors:  K P Rumbaugh; J A Griswold; B H Iglewski; A N Hamood
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific.

Authors:  Christian Fritz; Silvia Maass; Andreas Kreft; Franz-Christoph Bange
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 8.  Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Authors:  Daniel J Hassett; John Cuppoletti; Bruce Trapnell; Sergei V Lymar; John J Rowe; Sang Sun Yoon; George M Hilliard; Kislay Parvatiyar; Moneesha C Kamani; Daniel J Wozniak; Sung Hei Hwang; Timothy R McDermott; Urs A Ochsner
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

Review 9.  Anaerobic bacteria in upper respiratory tract and other head and neck infections.

Authors:  Itzhak Brook
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-05       Impact factor: 1.547

Review 10.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  53 in total

1.  FNR is a global regulator of virulence and anaerobic metabolism in Salmonella enterica serovar Typhimurium (ATCC 14028s).

Authors:  Ryan C Fink; Matthew R Evans; Steffen Porwollik; Andres Vazquez-Torres; Jessica Jones-Carson; Bryan Troxell; Stephen J Libby; Michael McClelland; Hosni M Hassan
Journal:  J Bacteriol       Date:  2007-01-12       Impact factor: 3.490

2.  Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice.

Authors:  Yutaka Kida; Takashi Shimizu; Koichi Kuwano
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.

Authors:  Kang-Mu Lee; Junhyeok Go; Mi Young Yoon; Yongjin Park; Sang Cheol Kim; Dong Eun Yong; Sang Sun Yoon
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

4.  Improving the efficiency of transposon mutagenesis in Salmonella enteritidis by overcoming host-restriction barriers.

Authors:  Turki M Dawoud; Tieshan Jiang; Rabindra K Mandal; Steven C Ricke; Young Min Kwon
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

5.  Characterization of the Pseudomonas aeruginosa NQR complex, a bacterial proton pump with roles in autopoisoning resistance.

Authors:  Daniel A Raba; Monica Rosas-Lemus; William M Menzer; Chen Li; Xuan Fang; Pingdong Liang; Karina Tuz; David D L Minh; Oscar Juárez
Journal:  J Biol Chem       Date:  2018-08-22       Impact factor: 5.157

6.  The Atypical Response Regulator AtvR Is a New Player in Pseudomonas aeruginosa Response to Hypoxia and Virulence.

Authors:  Gilberto Hideo Kaihami; Leandro Carvalho Dantas Breda; José Roberto Fogaça de Almeida; Thays de Oliveira Pereira; Gianlucca Gonçalves Nicastro; Ana Laura Boechat; Sandro Rogério de Almeida; Regina Lúcia Baldini
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

7.  The O2-independent pathway of ubiquinone biosynthesis is essential for denitrification in Pseudomonas aeruginosa.

Authors:  Chau-Duy-Tam Vo; Julie Michaud; Sylvie Elsen; Bruno Faivre; Emmanuelle Bouveret; Frédéric Barras; Marc Fontecave; Fabien Pierrel; Murielle Lombard; Ludovic Pelosi
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

8.  Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions.

Authors:  Mark D Platt; Michael J Schurr; Karin Sauer; Gustavo Vazquez; Irena Kukavica-Ibrulj; Eric Potvin; Roger C Levesque; Amber Fedynak; Fiona S L Brinkman; Jill Schurr; Sung-Hei Hwang; Gee W Lau; Patrick A Limbach; John J Rowe; Michael A Lieberman; Nicolas Barraud; Jeremy Webb; Staffan Kjelleberg; Donald F Hunt; Daniel J Hassett
Journal:  J Bacteriol       Date:  2008-01-18       Impact factor: 3.490

9.  Duckweed (Lemna minor) as a model plant system for the study of human microbial pathogenesis.

Authors:  Yong Zhang; Yangbo Hu; Baoyu Yang; Fang Ma; Pei Lu; Lamei Li; Chengsong Wan; Simon Rayner; Shiyun Chen
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

10.  Compensatory periplasmic nitrate reductase activity supports anaerobic growth of Pseudomonas aeruginosa PAO1 in the absence of membrane nitrate reductase.

Authors:  Nadine E Van Alst; Lani A Sherrill; Barbara H Iglewski; Constantine G Haidaris
Journal:  Can J Microbiol       Date:  2009-10       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.